Compare AOUT & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOUT | IVVD |
|---|---|---|
| Founded | 2020 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.5M | 212.6M |
| IPO Year | 2020 | 2021 |
| Metric | AOUT | IVVD |
|---|---|---|
| Price | $17.36 | $0.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $18.33 | $10.00 |
| AVG Volume (30 Days) | 134.6K | ★ 3.9M |
| Earning Date | 12-08-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.02 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $190,536,000.00 | $53,426,000.00 |
| Revenue This Year | $7.72 | $12.40 |
| Revenue Next Year | $5.30 | $44.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 110.47 |
| 52 Week Low | $6.26 | $0.53 |
| 52 Week High | $19.50 | $3.07 |
| Indicator | AOUT | IVVD |
|---|---|---|
| Relative Strength Index (RSI) | 51.62 | 39.90 |
| Support Level | $17.11 | $0.53 |
| Resistance Level | $18.08 | $1.02 |
| Average True Range (ATR) | 0.90 | 0.05 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 23.64 | 27.93 |
American Outdoor Brands Inc is the provider of outdoor lifestyle products and shooting sports accessories encompassing hunting, fishing, meat processing, outdoor cooking, shooting, and personal security and defense products for rugged outdoor enthusiasts. It conceive, design, produce or source, and sell its outdoor lifestyle products including premium sportsman knives, land management tools, products used while hunting, meat processing equipment; and outdoor cooking products and hooting sports accessories, including rests, vaults, and other related accessories, electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips, etc. The company operate as one reporting segment.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.